This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walters, M. R. Articles by Lees, K. R. Search for Related Content PubMed PubMed Citation Articles by Walters, M. R. Articles by Lees, K. R. Related Collections Brain Circulation and Metabolism Carotid Stenosis

(Stroke. 2001;32:473.)
© 2001 American Heart Association, Inc.

Original Contributions

Effect of Perindopril on Cerebral and Renal Perfusion in Stroke Patients With Carotid Disease

M. R. Walters, MD; A. Bolster, PhD; A. G. Dyker, MD K. R. Lees, MD

From the University Department of Medicine and Therapeutics (M.R.W., A.G.D., K.R.L.) and Department of Nuclear Medicine (A.B.), University of Glasgow, Glasgow, Scotland, UK.

Correspondence to Dr M.R. Walters, University Department of Medicine and Therapeutics, University of Glasgow, Glasgow, Scotland, UK. E-mail m.walters{at}clinmed.gla.ac.uk

Background and Purpose—The purpose of this study was to investigate the effect of the angiotensin-converting enzyme inhibitor perindopril on mean arterial blood pressure (MABP), cerebral blood flow (CBF), and glomerular filtration rate in hypertensive stroke patients with moderate to severe internal carotid artery (ICA) disease or ICA occlusion.

Methods—Twenty-four nonacute ischemic stroke patients who had MABP readings >100 mm Hg and moderate to severe ICA stenosis or occlusion were randomized to receive perindopril 4 mg daily or placebo for 14 days. MABP, ICA flow, and both middle cerebral artery (MCA) velocity and resistance index were measured before dose, at 5 time points over the subsequent 24 hours, and finally at 2 weeks. Brain hexamethyl propylene amine oxide single photon emission computed tomography scans were performed before drug administration and at time of peak drug effect (6 to 8 hours) after the first dose. Glomerular filtration rate was measured with ⁵¹Cr EDTA before medication and at 14 days.

Results—A placebo-corrected BP fall of 17/10 mm Hg was seen (P=0.017), which was maximal at 5.5 hours. No significant change in ICA flow or MCA velocity was seen between groups. No significant change in hemispheric CBF was seen. The mean change from baseline in the treated group was -0.79 mL · 100 g^-1 · min^-1 (95% confidence interval [CI], 1.65 to -3.23); mean change in the placebo group was -1.9 mL · 100 g^-1 · min^-1 (95%CI, 3.02 to -6.92). Peri-infarct CBF was similarly unaffected. One of the treated patients developed transient acute renal impairment and was withdrawn from the study on day 4.

Conclusions—Perindopril lowers BP without lowering CBF in hypertensive stroke patients with moderate to severe ICA stenosis or occlusion; monitoring of this patient population for the complications of renal artery stenosis should be considered.

Key Words: angiotensin-converting enzyme inhibitors • carotid artery stenosis • cerebral blood flow

This article has been cited by other articles:

				T. N. Turan, G. Cotsonis, M. J. Lynn, S. Chaturvedi, M. Chimowitz, and for the Warfarin-Aspirin Symptomatic Intracranial Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis Circulation, June 12, 2007; 115(23): 2969 - 2975. [Abstract] [Full Text] [PDF]

				G. Zuliani, A. Cherubini, S. Volpato, A. R. Atti, A. Ble, C. Vavalle, F. Di Todaro, C. Benedetti, C. Ruggiero, U. Senin, et al. Treatment With Angiotensin-Converting Enzyme Inhibitors Is Associated With a Reduction in Short-Term Mortality in Older Patients With Acute Ischemic Stroke J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 463 - 465. [Abstract] [Full Text] [PDF]

				J. Hatazawa, E. Shimosegawa, Y. Osaki, M. Ibaraki, N. Oku, S. Hasegawa, K. Nagata, Y. Hirata, and Y. Miura Long-Term Angiotensin-Converting Enzyme Inhibitor Perindopril Therapy Improves Cerebral Perfusion Reserve in Patients With Previous Minor Stroke Stroke, September 1, 2004; 35(9): 2117 - 2122. [Abstract] [Full Text] [PDF]

				M. Walters, S. Muir, I. Shah, and K. Lees Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction Stroke, August 1, 2004; 35(8): 1899 - 1902. [Abstract] [Full Text] [PDF]

				S. I. Sokol, E. L. Portnay, J. P. Curtis, M. A. Nelson, P. R. Hebert, J. F. Setaro, and J. M. Foody Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke Neurology, July 27, 2004; 63(2): 208 - 213. [Abstract] [Full Text] [PDF]

				K. W Muir Secondary prevention for stroke and transient ischaemic attacks: Author's reply BMJ, April 10, 2004; 328(7444): 897 - 897. [Full Text]

				K. W Muir Secondary prevention for stroke and transient ischaemic attacks BMJ, February 7, 2004; 328(7435): 297 - 298. [Full Text] [PDF]

				P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]